AXIM BIOTECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $103.82 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2023-05-22
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2023-03-31 was $103.82K, a 45.04% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-09-30 was $517.18K, a 485.62% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-06-30 was -$188.92K, a 306.41% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-03-31 was $188.92K.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $1.11M, a 3.17% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $1.14M, a 41.28% decline from fiscal 2020.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2020 was $1.95M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | $103.82K 10-Q · filed 2023-05-22 | ||||
| 2022-12-31 | $1.11M 10-K · filed 2023-04-17 | ||||
| 2022-09-30 | $517.18K 10-Q/A · filed 2022-11-15 | $328.26K derived: sum of 2 quarters · filed 2022-11-15 | $761.81K 10-Q/A · filed 2022-11-15 | $707.83K derived: sum of 4 quarters · filed 2023-05-22 | |
| 2022-06-30 | -$188.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | $0.00 10-Q · filed 2022-08-16 | $190.65K derived: sum of 3 quarters · filed 2023-05-22 | $278.97K derived: sum of 4 quarters · filed 2023-05-22 | |
| 2022-03-31 | $188.92K 10-Q · filed 2023-05-22 | $188.92K 10-Q · filed 2022-05-23 | $379.57K derived: sum of 2 quarters · filed 2023-05-22 | $467.88K derived: sum of 3 quarters · filed 2023-05-22 | $559.41K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $190.65K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | $278.97K derived: sum of 2 quarters · filed 2023-04-17 | $370.49K derived: sum of 3 quarters · filed 2023-04-17 | $1.14M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $88.31K 10-Q/A · filed 2022-11-15 | $761.81K 10-Q · filed 2021-11-22 | $179.84K derived: sum of 2 quarters · filed 2022-11-15 | $953.08K 10-Q/A · filed 2022-11-15 | $1.35M derived: sum of 4 quarters · filed 2022-11-15 |
| 2021-06-30 | $91.53K 10-Q · filed 2021-08-23 | $191.27K 10-Q · filed 2021-08-23 | $1.26M derived: sum of 3 quarters · filed 2022-08-16 | $1.26M derived: sum of 4 quarters · filed 2022-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-08-16 | $99.74K 10-Q · filed 2022-05-23 | $1.17M derived: sum of 2 quarters · filed 2022-08-16 | $1.17M derived: sum of 3 quarters · filed 2022-08-16 | $1.17M derived: sum of 4 quarters · filed 2022-08-16 |
| 2020-12-31 | $1.17M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-19 | $1.17M derived: sum of 2 quarters · filed 2022-04-19 | $1.17M derived: sum of 3 quarters · filed 2022-04-19 | $1.95M 10-K/A · filed 2022-04-19 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-22 | $0.00 derived: sum of 2 quarters · filed 2021-11-22 | $779.03K 10-Q · filed 2021-11-22 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-23 | $0.00 10-Q · filed 2021-08-23 | |||
| 2019-06-30 | $227.50K 10-Q/A · filed 2020-11-27 |